AdaptHealth Corp. (NASDAQ:AHCO) Q2 2020 Earnings Conference Call August 4, 2020 8:30 AM ET Company Participants Chris Joyce - General Counsel Josh Parnes - President Luke McGee - Chief Executive Officer Gregg Holst - Retiring Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Stephen Tanal - SVB Leerink Brian Tanquilut - Jeffries Mathew Blackman - Stifel Anton Hie - RBC Capital Markets Richard Close - Canaccord Genuity Operator Greetings, and welcome to AdaptHealth Corp. se ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specified in its charter) | Delaware | 82-3677704 | | --- | --- | | (State of Other Jurisdiction of in ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001‑38399 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 82‑3677704 (State of Other Jurisdiction of incorporation or Organi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001‑38399 AdaptHealth Corp. (Exact name of registrant as specified in its charter) | Delaware | 82‑3677704 | | --- | --- | | (State of Other Jurisdiction of incorp ...

Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 780 Third Avenue, New York, NY 10017 OR (Address of principal executive offices) (Zip Code) (212) 551-1600 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38399 DFB HEALTHCARE ACQUISITIONS CORP. (Exact name of registrant as specified in its charter) Delaware 82-367 ...

Table of Contents Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38399 DFB HEALTHCARE ACQUISITIONS CORP. (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Exact name of registrant as specified in its charter) Delaware 82-36 ...